Similarly, most hub genes in the NAFLD vs. cirrhosis group were dysregulated, except for UGT2B17 and CYP26B1. While the dysregulation of UGT2B17 and CYP26B1 genes is not directly associated with NAFLD, their role in metabolic processes leading to the disease is reported [46, 47]. The gene discussed is UGT2B17; the disease is metabolic dysfunction-associated steatotic liver disease.